AKT1 and central nervous system cancer: Recently, Chaudhuri et al. demonstrated that T11TS administration relieved the glioma-induced suppression of the PI3K-AKT pathway in T-cells, which may result in decreased T-cell apoptosis and increased T-cell survival in the glioma microenvironment (99).